ReviewCureus2025
Optic Nerve Sheath Measurements for Noninvasive Monitoring of Malignant Supratentorial Infarcts: A Systematic Review and Meta-Analysis.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEarly detection of malignant supratentorial infarcts, particularly malignant middle cerebral artery (MCA), is crucial; however, advanced imaging techniques such as MRI and PET are often inaccessible in resource-limited areas. A potential solution for early risk stratification of stroke patients is the optic nerve sheath diameter (ONSD) measured by transorbital ultrasound. The purpose of this study was to evaluate the utility of optic nerve sheath imaging measurements in recognizing malignant infarcts. A meta-analysis on ONSD measurement has been done for acute ischemic stroke patients.
methodsFollowing Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2022 guidelines, a comprehensive search was conducted for studies published between January 2000 and December 2023. A total of six eligible studies were included. These studies were observational studies involving adult patients diagnosed with malignant supratentorial infarcts who underwent ONSD assessment using ultrasonography, computed tomography (CT), or magnetic resonance imaging (MRI). Data extraction and risk of bias assessments were performed independently. A meta-analysis was conducted to pool estimates of mean ONSD measurement, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy using the metamean() and metaprop() functions from the meta R package.
resultsFour studies (n = 170) show a high detection rate of 89.01% (95% CI: 82.88-93.13) with low heterogeneity (I² = 21.3%) based on CT findings of malignant middle cerebral artery (MCA) infarction or progression of acute ischemic stroke. Six studies (n = 314) reporting ONSD showed a pooled mean of 5.50 mm (95% CI: 5.24-5.76 mm), though heterogeneity was substantial (I² = 97.0%). Findings show a sensitivity of 89.01%, specificity of 82.94% to 86.63%, PPV of 81.37%, NPV of 92.57%, and overall diagnostic accuracy of 87.82%. An optimal ONSD cutoff value across studies of 4.70 mm to 5.60 mm, with 5.60 mm, demonstrates the highest diagnostic yield (Youden's Index = 0.8947).
conclusionONSD measurements can be used in determining malignant infarcts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.